Meet us at #ATW26 in San Diego, February 9-12.
Our Team
Our Services
CMC
Regulatory
Nonclinical
Clinical
Quality & Compliance
Supply Chain
Commercial Launch
Business Analytics
View all Services
Our Advantage
More
Our Global Offices
General Inquiries
Careers/RbD
Our Values
Conference Schedule
Press Room
Regulatory Roundup
DHCG Webinars
Print Library
Testimonials
Annual Lookback (Latest)
Annual Lookback (Back Issues)
Quarter Horse Archive
QMS in a Box
Privacy Policy
Terms of Service
Ready to accelerate your program?
Request Consultation
Contact Us
Case Study Library
Request Consultation
Back to resources
Thought Leadership Expertise
Press Room
Choose a category…
Straight From the Horse’s Mouth
White Papers
Publications
Choose a tag…
3PL
Best Practices
Cell & Gene Therapy
Clinical
Clinical Operations
Clinical Supply Chain Management
CMC
Commercial
Commercial Launch
Commercial Supply Chain Launch Readiness
Commercial Systems
Demand & Operations Planning
Finance
General
Global Trade Compliance
Info Sheets
IT
Logistics
Manufacturing
Mature
Medical Affairs
Operational Excellence
Perspective
Press Room
Preclinical
Publications
Quality
Serialization
Supply Chain
Supply Chain Planning & Digitization
Supply Planning
Supply Risk Management
Uncategorized
White Papers
Nate Manley March 2021 interview in Cell and Gene Insights
Manufacturing costs the ‘biggest threat’ to cell and gene therapies
Katy Spink in Precision Medicine Online
ISCT Join as Strategic Partners for Phacilitate Trade Mission to Japan and South Korea
Heath Coats joins Dark Horse Consulting Group as Senior Practice Expert
Dr. Kim Benton on finalized guidance for AMT designation program
Finding closure: Lowering the costs of cell and gene therapies
Dr. Kim Benton on FDA's Draft Platform Guidance for CGT
Don Fink in cellandgene.com on EMA Guideline implementation
Previous
Next
